The Effect of Antiangiogenic Therapy With Pazopanib Prior to Preoperative Chemotherapy for Subjects With Extremity Soft Tissue Sarcomas: A Randomized Study to Evaluate Response by Imaging

Trial Profile

The Effect of Antiangiogenic Therapy With Pazopanib Prior to Preoperative Chemotherapy for Subjects With Extremity Soft Tissue Sarcomas: A Randomized Study to Evaluate Response by Imaging

Active, no longer recruiting
Phase of Trial: Phase II

Latest Information Update: 17 Nov 2016

At a glance

  • Drugs Pazopanib (Primary) ; Doxorubicin; Ifosfamide
  • Indications Soft tissue sarcoma
  • Focus Pharmacokinetics; Therapeutic Use
  • Most Recent Events

    • 05 Apr 2016 Status changed from recruiting to active, no longer recruiting, according to ClinicalTrials.gov record.
    • 14 Dec 2015 Planned primary completion date changed from 1 Apr 2016 to 1 Oct 2016 as per ClinicalTrials.gov record.
    • 05 May 2015 Planned primary completion date changed from 1 Apr 2015 to 1 Apr 2016 as reported by ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top